|
CA3074865A1
|
|
Methods of detection using x-ray fluorescence
|
|
WO2017184564A1
|
|
Sensors and sensor arrays for detection of analytes
|
|
EP2536718A1
|
|
Heterocycles as potassium channel modulators
|
|
AP201105788A0
|
|
Sulfonamide derivatives
|
|
WO2010033824A1
|
|
Sulfonamide derivatives as inhibitors of ion channels
|
|
US2010056637A1
|
|
Treatment methods using triaryl methane compounds
|
|
CA2696631A1
|
|
Heterocycles as potassium channel modulators
|
|
EP2183644A1
|
|
Well plate for xrf measurements
|
|
CA2693588A1
|
|
Sodium channel inhibitors
|
|
WO2009012241A1
|
|
Sodium channel inhibitors
|
|
CA2681572A1
|
|
Inhibitors of ion channels
|
|
AU2007202750A1
|
|
SL02 and SL04, novel potassium channel proteins from human brain
|
|
US2007173504A1
|
|
Calcium channel antagonists
|
|
AU2006327173A1
|
|
Calcium channel antagonists
|
|
AU2006331653A1
|
|
Treatment methods using triaryl methane compounds
|
|
AU2006311954A1
|
|
Inhibitors of ion channels
|
|
US2007078145A1
|
|
Inhibitors of ion channels
|
|
WO2006084031A1
|
|
Imines as ion channel modulators
|
|
US2005267032A1
|
|
Sulfone-containing prodrugs
|
|
EP1740155A1
|
|
Polycylic thiazoles as potassium ion channel modulators
|
